Jefferies Reiterates a “Buy” Rating on Dexcom (DXCM) and $70.0 Target; Shorts at SBI HOLDINGS (SBHGF) Raised By 145.85%

December 23, 2017 - By Jerrie Dane

SBI HOLDINGS INCORPORATED (OTCMKTS:SBHGF) had an increase of 145.85% in short interest. SBHGF’s SI was 595,700 shares in December as released by FINRA. Its up 145.85% from 242,300 shares previously. With 3,700 avg volume, 161 days are for SBI HOLDINGS INCORPORATED (OTCMKTS:SBHGF)’s short sellers to cover SBHGF’s short positions. The stock decreased 4.55% or $0.99 during the last trading session, reaching $20.75. About 36,808 shares traded or 1069.99% up from the average. SBI Holdings, Inc. (OTCMKTS:SBHGF) has 0.00% since December 23, 2016 and is . It has underperformed by 16.70% the S&P500.

Among 23 analysts covering Dexcom (NASDAQ:DXCM), 17 have Buy rating, 0 Sell and 6 Hold. Therefore 74% are positive. Dexcom has $120 highest and $52 lowest target. $76.94’s average target is 37.10% above currents $56.12 stock price. Dexcom had 59 analyst reports since August 6, 2015 according to SRatingsIntel. Oppenheimer maintained the stock with “Buy” rating in Monday, June 5 report. The company was maintained on Thursday, September 28 by Robert W. Baird. The rating was maintained by Cowen & Co on Wednesday, December 20 with “Buy”. As per Thursday, September 28, the company rating was downgraded by Raymond James. The company was maintained on Thursday, September 28 by Canaccord Genuity. The rating was maintained by Morgan Stanley with “Neutral” on Friday, November 3. The stock of DexCom, Inc. (NASDAQ:DXCM) earned “Buy” rating by BTIG Research on Monday, October 31. The rating was maintained by Benchmark with “Buy” on Wednesday, February 24. Cowen & Co maintained the stock with “Buy” rating in Thursday, July 13 report. BMO Capital Markets maintained the stock with “Buy” rating in Wednesday, September 27 report.

SBI Holdings, Inc., together with its subsidiaries, engages in the online financial service businesses and investment activities in Japan and internationally. The company has market cap of $4.08 billion. It operates through Financial Services Business, Asset Management Business, and Biotechnology-Related Business divisions. It has a 13.45 P/E ratio. The Financial Services Business segment provides various financial services and products, including brokerage and investment banking, banking, nonlife insurance and short-term small-amount insurance, and housing loan services; economic and investment information services; and credit card, leasing, remittance, peer-to-peer lending, and other services, as well as foreign-exchange market participant services.

Analysts await DexCom, Inc. (NASDAQ:DXCM) to report earnings on February, 27. They expect $0.03 earnings per share, up 133.33% or $0.12 from last year’s $-0.09 per share. DXCM’s profit will be $2.61 million for 467.67 P/E if the $0.03 EPS becomes a reality. After $-0.03 actual earnings per share reported by DexCom, Inc. for the previous quarter, Wall Street now forecasts -200.00% EPS growth.

Investors sentiment decreased to 0.97 in 2017 Q3. Its down 0.39, from 1.36 in 2017Q2. It worsened, as 59 investors sold DexCom, Inc. shares while 69 reduced holdings. 31 funds opened positions while 93 raised stakes. 98.30 million shares or 1.76% more from 96.59 million shares in 2017Q2 were reported. 811 are held by Winslow Capital Ltd Co. Ellington Mgmt Group Ltd Liability Corp stated it has 0.1% of its portfolio in DexCom, Inc. (NASDAQ:DXCM). Moreover, Dimensional Fund Advsrs Limited Partnership has 0% invested in DexCom, Inc. (NASDAQ:DXCM). The Massachusetts-based Massachusetts Fincl Services Ma has invested 0.01% in DexCom, Inc. (NASDAQ:DXCM). Old Natl Bank In has invested 0.03% in DexCom, Inc. (NASDAQ:DXCM). Banque Pictet And Cie Sa reported 101,830 shares. Svcs has invested 0% in DexCom, Inc. (NASDAQ:DXCM). Northern Tru reported 0.01% in DexCom, Inc. (NASDAQ:DXCM). Stephens Invest Management Group Ltd Liability Corp accumulated 192,324 shares. Cubist Systematic Strategies Ltd Liability Com has 2,385 shares. Bokf Na stated it has 0.01% in DexCom, Inc. (NASDAQ:DXCM). Assetmark Inc invested 0% in DexCom, Inc. (NASDAQ:DXCM). Geode Capital Mgmt Ltd Liability stated it has 792,339 shares or 0.01% of all its holdings. Hightower Advsrs Limited Liability Com holds 87,950 shares or 0.04% of its portfolio. Tocqueville Asset Mngmt L P accumulated 0% or 8,429 shares.

Since August 10, 2017, it had 0 insider purchases, and 11 sales for $2.56 million activity. On Monday, September 11 the insider Balo Andrew K sold $234,441. 1,450 shares were sold by Pacelli Steven Robert, worth $101,219. 1,635 shares were sold by DOUBLEDAY RICHARD, worth $73,274 on Monday, October 23. Another trade for 6,000 shares valued at $353,092 was sold by SAYER KEVIN R.

DexCom, Inc., a medical device company, together with its subsidiaries, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. The company has market cap of $4.88 billion. The firm offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. It currently has negative earnings. The Company’s products include DexCom G4 PLATINUM system for continuous use by adults with diabetes; DexCom G4 PLATINUM with Share, a remote monitoring system; and DexCom G5 Mobile, a CGM system that directly communicates to a patientÂ’s mobile and its data can be integrated with DexCom CLARITY, which is a next generation cloud reporting software for personalized, easy-to-understand analysis of trends to improve diabetes management.